{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:35:57Z","timestamp":1741754157761,"version":"3.38.0"},"reference-count":35,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"DOI":"10.4274\/tjps.galenos.2024.92185","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T10:22:51Z","timestamp":1741342971000},"page":"26-37","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge and Attitude of Iraqi Pharmacists Regarding the Adverse Effects of NSAIDs Based on Years of Experience"],"prefix":"10.4274","volume":"22","author":[{"given":"Hala Fouad","family":"KASIM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina \u0130brahim","family":"SAL\u0130H","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder","family":"AL HAMDANY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2007","unstructured":"1. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136-147.","journal-title":"Br J Clin Pharmacol"},{"key":"ref1","unstructured":"2. U.S. Food and Drug Administration. FDA strengthens warning that non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. 2015. Available at: https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM453941.pdf [Accessed 12 Dec. 2023]."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jsps.2020.03.001","article-title":"Non-steroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug-drug interactions among elderly patients: a study from Jordan","volume":"28","author":"Al-Azayzih","year":"2020","unstructured":"3. Al-Azayzih A, Al-Azzam SI, Alzoubi KH, Jarab AS, Kharaba Z, Al-Rifai RH, Alnajjar MS. Non-steroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug-drug interactions among elderly patients: a study from Jordan. Saudi Pharm J. 2020;28:504-508.","journal-title":"Saudi Pharm J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.15537\/smj.2020.8.25221","article-title":"Evaluation of the community pharmacists' performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi Arabia","volume":"41","author":"Malebari","year":"2020","unstructured":"4. Malebari AM, Khayyat AN, Mahdali RA, Alamoudi JS, Alsayed BY, Alrasheed SA. Evaluation of the community pharmacists' performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi Arabia. Saudi Med J. 2020;41:849-857.","journal-title":"Saudi Med J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","unstructured":"5. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9:143-150.","journal-title":"Aging Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1017\/S1463423618000142","article-title":"Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand","volume":"19","author":"Phueanpinit","year":"2018","unstructured":"6. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Prim Health Care Res Dev. 2018;19:598-604.","journal-title":"Prim Health Care Res Dev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ejp.1459","article-title":"Self-medication in pain management: the state of the art of pharmacists' role for optimal over-the-counter analgesic use","volume":"23","author":"Perrot","year":"2019","unstructured":"7. Perrot S, Citt\u00e9e J, Louis P, Quentin B, Robert C, Milon JY, Bismut H, Baumelou A. Self-medication in pain management: the state of the art of pharmacists' role for optimal over-the-counter analgesic use. Eur J Pain. 2019;23:1747-1762.","journal-title":"Eur J Pain"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40266-016-0358-1","article-title":"Medication safety systems and the important role of pharmacists","volume":"33","author":"Mansur","year":"2016","unstructured":"8. Mansur JM. Medication safety systems and the important role of pharmacists. Drugs Aging. 2016;33:213-221.","journal-title":"Drugs Aging"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052-2081.","DOI":"10.1111\/jgs.18372"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/JPR.S75160","article-title":"New insights into the use of currently available non-steroidal anti-inflammatory drugs","volume":"8","author":"Brune","year":"2015","unstructured":"10. Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105-118.","journal-title":"J Pain Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1517\/14740338.2016.1139571","article-title":"Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand","volume":"15","author":"Jarernsiripornkul","year":"2016","unstructured":"11. Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;15:417-426.","journal-title":"Expert Opin Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1186\/s12889-018-6019-z","article-title":"Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain","volume":"18","author":"G\u00f3mez-Acebo","year":"2018","unstructured":"12. G\u00f3mez-Acebo I, Dierssen-Sotos T, de Pedro M, P\u00e9rez-G\u00f3mez B, Casta\u00f1o-Vinyals G, Fern\u00e1ndez-Villa T, Palazuelos-Calder\u00f3n C, Amiano P, Etxeberria J, Benavente Y, Fern\u00e1ndez-Tard\u00f3n G, Salcedo-Bellido I, Capelo R, Peir\u00f3 R, Marcos-Gragera R, Huerta JM, Tard\u00f3n A, Barricarte A, Altzibar JM, Alonso-Molero J, D\u00e1vila-Batista V, Aragon\u00e9s N, Poll\u00e1n M, Kogevinas M, Llorca J. Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. BMC Public Health. 2018;18:1134.","journal-title":"BMC Public Health"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061-1075.","DOI":"10.2147\/TCRM.S79135"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Foppe van Mil JW, Westerlund T, Brown L, Chen TF, Henman M, Hersberger K, McElnay J, Schulz M. Medical care and drug-related problems: do doctors and pharmacists speak the same language? Int J Clin Pharm. 2016;38:191-194.","DOI":"10.1007\/s11096-016-0249-x"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/ijerph20021635","article-title":"Assessment of knowledge, attitude and practices of the hospital and Community Pharmacists in Saudi Arabia (Jeddah) towards Inappropriate Medication Use in Older Adults","volume":"20","author":"Alfahmi","year":"2023","unstructured":"15. Alfahmi AA, Curtain CM, Salahudeen MS. Assessment of knowledge, attitude and practices of the hospital and Community Pharmacists in Saudi Arabia (Jeddah) towards Inappropriate Medication Use in Older Adults. Int J Environ Res Public Health. 2023;20:1635.","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11096-019-00867-7","article-title":"Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study","volume":"41","author":"Hussain","year":"2019","unstructured":"16. Hussain SA, Abbas AN, Habeeb SA, Abd-Ali AK, Abdulrahman ZS. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study. Int J Clin Pharm. 2019;41:1307-1313.","journal-title":"Int J Clin Pharm"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3897\/pharmacia.69.e95691","article-title":"Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region-Iraq: hampered and perspective","volume":"69","author":"Allela","year":"2022","unstructured":"17. Allela O. Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region-Iraq: hampered and perspective. Pharmacia. 2022;69:1057-1062.","journal-title":"Pharmacia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.26719\/emhj.21.025","article-title":"Pharmaceutical regulations in Iraq: from medicine approval to postmarketing","volume":"27","author":"Al-Jumaili","year":"2021","unstructured":"18. Al-Jumaili AA, Younus MM, Kannan YJA, Nooruldeen ZE, Al-Nuseirat A. Pharmaceutical regulations in Iraq: from medicine approval to postmarketing. East Mediterr Health J. 2021;27:1007-1015.","journal-title":"East Mediterr Health J"},{"key":"ref18","unstructured":"19. The invisible burden of antibiotic resistance in Mosul, Iraq, MSF. 2019. Available at: https:\/\/www.msf.org\/invisible-burden-antibiotic-resistance-mosul-iraq [Accessed 13 Dec. 2023]."},{"key":"ref19","unstructured":"20. Sample Size Calculator by Raosoft, Inc. Available at: http:\/\/www.raosoft.com\/samplesize.html [Accessed 13 Nov. 2023]."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jsps.2022.06.011","article-title":"Assessment of Qatar community pharmacists' competence and practices related to renal and gastrointestinal adverse effects of non-prescription NSAIDs","volume":"30","author":"Owusu","year":"2022","unstructured":"21. Owusu YB, Elkhalifa WH, Awaisu A, Kheir N. Assessment of Qatar community pharmacists' competence and practices related to renal and gastrointestinal adverse effects of non-prescription NSAIDs. Saudi Pharm J. 2022;30:1396-1404.","journal-title":"Saudi Pharm J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11096-014-0018-7","article-title":"Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand","volume":"36","author":"Phueanpinit","year":"2014","unstructured":"22. Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36:1205-1212.","journal-title":"Int J Clin Pharm"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Morrison C, Beauchamp T, MacDonald H, Beattie M. Implementing a non-steroidal anti-inflammatory drugs communication bundle in remote and rural pharmacies and dispensing practices. BMJ Open Qual. 2018;7:e000303.","DOI":"10.1136\/bmjoq-2017-000303"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/pds.4792","article-title":"Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process","volume":"28","author":"Kopciuch","year":"2019","unstructured":"24. Kopciuch D, Zaprutko T, Paczkowska A, Ratajczak P, Zieli\u0144ska-Tomczak \u0141, Kus K, Nowakowska E. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Pharmacoepidemiol Drug Saf. 2019;28:1543-1551.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11096-020-00966-w","article-title":"High-risk nonsteroidal anti-inflammatory drugs prescribing in primary care: results from National Medical Care Survey Malaysia","volume":"42","author":"Hwong","year":"2020","unstructured":"25. Hwong WY, Lim YMF, Khoo EM, Sivasampu S. High-risk nonsteroidal anti-inflammatory drugs prescribing in primary care: results from National Medical Care Survey Malaysia. Int J Clin Pharm. 2020;42:489-499.","journal-title":"Int J Clin Pharm"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s40267-019-00621-z","article-title":"Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomized controlled trial","volume":"35","author":"Cheema","year":"2019","unstructured":"26. Cheema E, Almualem AA, Basudan AT, Salamatullah AK, Radhwi SO, Alsehli AS. Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomized controlled trial. Drugs Ther Perspect. 2019;35:296-300.","journal-title":"Drugs Ther Perspect"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.37022\/jiaps.v8i2.464","article-title":"Empowering pharmacovigilance: unleashing the potential of generative AI in drug safety monitoring","volume":"8","author":"Praveen","year":"2023","unstructured":"27. Praveen J. Empowering pharmacovigilance: unleashing the potential of generative AI in drug safety monitoring. J Innov Appl Pharm Sci. 2023;8:24-32.","journal-title":"J Innov Appl Pharm Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/ijpp.12538","article-title":"Practices of healthcare professionals in communicating with non-steroidal anti-inflammatory drug users in Thailand: a qualitative study","volume":"27","author":"Jarernsiripornkul","year":"2019","unstructured":"28. Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Practices of healthcare professionals in communicating with non-steroidal anti-inflammatory drug users in Thailand: a qualitative study. Int J Pharm Pract. 2019;27:362-369.","journal-title":"Int J Pharm Pract"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/jep.12806","article-title":"Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients","volume":"23","author":"Phueanpinit","year":"2017","unstructured":"29. Phueanpinit P, Pongwecharak J, Sumanont S, Krska J, Jarernsiripornkul N. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients. J Eval Clin Pract. 2017;23:1387-1394.","journal-title":"J Eval Clin Pract"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pec.2010.10.032","article-title":"Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness","volume":"83","author":"Schmitt","year":"2011","unstructured":"30. Schmitt MR, Miller MJ, Harrison DL, Farmer KC, Allison JJ, Cobaugh DJ, Saag KG. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness. Patient Educ Couns. 2011;83:391-397.","journal-title":"Patient Educ Couns"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s11096-016-0363-9","article-title":"Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopedic patients in Thailand","volume":"38","author":"Phueanpinit","year":"2016","unstructured":"31. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopedic patients in Thailand. Int J Clin Pharm. 2016;38:1269-1276.","journal-title":"Int J Clin Pharm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s11096-020-00984-8","article-title":"Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications","volume":"42","author":"Yl\u00e4-Rautio","year":"2020","unstructured":"32. Yl\u00e4-Rautio H, Siissalo S, Leikola S. Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. Int J Clin Pharm. 2020;42:786-795.","journal-title":"Int J Clin Pharm"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.18549\/PharmPract.2015.04.597","article-title":"The practice of OTC counseling by community pharmacists in Parana, Brazil","volume":"13","author":"Halila","year":"2015","unstructured":"33. Halila GC, Junior EH, Otuki MF, Correr CJ. The practice of OTC counseling by community pharmacists in Parana, Brazil. Pharm Pract (Granada). 2015;13:597.","journal-title":"Pharm Pract (Granada)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4172\/2329-6887.1000214","article-title":"Physicians' knowledge about pharmacovigilance in Iraq","volume":"4","author":"RMS","year":"2016","unstructured":"34. RMS M, YA A. Physicians' knowledge about pharmacovigilance in Iraq. J Pharmacovigil. 2016;4:13.","journal-title":"J Pharmacovigil"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jsps.2018.04.012","article-title":"Knowledge, attitudes, and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study","volume":"26","author":"TM","year":"2018","unstructured":"35. AlShammari TM, Almoslem MJ. Knowledge, attitudes, and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study. Saudi Pharm J. 2018;26:925-931.","journal-title":"Saudi Pharm J"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:40:41Z","timestamp":1741696841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.turkjps.org\/articles\/knowledge-and-attitude-of-iraqi-pharmacists-regarding-the-adverse-effects-of-nsaids-based-on-years-of-experience\/doi\/tjps.galenos.2024.92185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,7]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2024.92185","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"type":"print","value":"1304-530X"},{"type":"electronic","value":"2148-6247"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}